Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Impact of sex work on risk behaviours and their association with HIV positivity among people who inject drugs in Eastern Central Canada: cross-sectional results from an open cohort study.

Campeau L, Blouin K, Leclerc P, Alary M, Morissette C, Blanchette C, Serhir B, Roy E; SurvUDI Working Group.

BMJ Open. 2018 Jan 31;8(1):e019388. doi: 10.1136/bmjopen-2017-019388.

2.

Three-Dimensional Ultrasound Imaging of Deep Infiltrating Endometriotic Lesions of the Bowel.

Flaxman TE, Singh SS, Morissette C, Della Zazzera V.

J Minim Invasive Gynecol. 2018 Jul - Aug;25(5):753-754. doi: 10.1016/j.jmig.2017.08.654. Epub 2017 Aug 31. No abstract available.

PMID:
28864045
3.

Drug use practices among people who inject drugs in a context of drug market changes: Challenges for optimal coverage of harm reduction programs.

Roy É, Arruda N, Leclerc P, Morissette C, Blanchette C, Blouin K, Alary M.

Int J Drug Policy. 2017 Jul;45:18-24. doi: 10.1016/j.drugpo.2017.05.012. Epub 2017 May 30.

PMID:
28575681
4.

The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study.

Cousien A, Leclerc P, Morissette C, Bruneau J, Roy É, Tran VC, Yazdanpanah Y, Cox J.

BMC Infect Dis. 2017 Feb 21;17(1):162. doi: 10.1186/s12879-017-2256-5.

5.

Sex Work as an Emerging Risk Factor for Human Immunodeficiency Virus Seroconversion Among People who Inject Drugs in the SurvUDI Network.

Blouin K, Leclerc P, Morissette C, Roy É, Blanchette C, Parent R, Serhir B, Alary M.

Sex Transm Dis. 2016 Oct;43(10):648-55. doi: 10.1097/OLQ.0000000000000504.

PMID:
27631361
6.

Estimating the size of the population of persons who inject drugs in the island of Montréal, Canada, using a six-source capture-recapture model.

Leclerc P, Vandal AC, Fall A, Bruneau J, Roy É, Brissette S, Archibald C, Arruda N, Morissette C.

Drug Alcohol Depend. 2014 Sep 1;142:174-80. doi: 10.1016/j.drugalcdep.2014.06.022. Epub 2014 Jun 24.

PMID:
25008106
7.

Prevalence and temporal trends of crack injection among injection drug users in eastern central Canada.

Roy E, Leclerc P, Morissette C, Arruda N, Blanchette C, Blouin K, Alary M.

Drug Alcohol Depend. 2013 Nov 1;133(1):275-8. doi: 10.1016/j.drugalcdep.2013.05.013. Epub 2013 Jun 12.

PMID:
23769158
8.

Temporal changes in risk factors associated with HIV seroconversion among injection drug users in eastern central Canada.

Roy E, Richer I, Morissette C, Leclerc P, Parent R, Claessens C, Blanchette C, Alary M.

AIDS. 2011 Sep 24;25(15):1897-903. doi: 10.1097/QAD.0b013e32834ad6bb.

PMID:
21785319
9.

Drug use patterns in the presence of crack in downtown Montréal.

Roy E, Arruda N, Vaillancourt E, Boivin JF, Morissette C, Leclerc P, Alary M, Bourgois P.

Drug Alcohol Rev. 2012 Jan;31(1):72-80. doi: 10.1111/j.1465-3362.2011.00299.x. Epub 2011 Mar 22.

10.

Application of 3-d angiography in the management of placenta percreta treated with repeat uterine artery embolization.

El-Messidi A, Morissette C, Faught W, Oppenheimer L.

J Obstet Gynaecol Can. 2010 Aug;32(8):775-9.

PMID:
21050511
11.

Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users.

Cox J, Morissette C, De P, Tremblay C, Allard R, Graves L, Stephenson R, Roy E.

Subst Use Misuse. 2009;44(4):548-68. doi: 10.1080/10826080802544349.

12.

Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review.

De P, Roy E, Boivin JF, Cox J, Morissette C.

J Viral Hepat. 2008 Apr;15(4):279-92. doi: 10.1111/j.1365-2893.2007.00942.x. Epub 2008 Jan 20.

13.

Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users.

Cox J, De P, Morissette C, Tremblay C, Stephenson R, Allard R, Graves L, Roy E.

Soc Sci Med. 2008 Jan;66(2):211-20. Epub 2007 Oct 24.

14.

Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.

Morissette C, Cox J, De P, Tremblay C, Roy E, Allard R, Stephenson R, Graves L.

Int J Drug Policy. 2007 May;18(3):204-12. Epub 2006 Oct 2.

PMID:
17689367
15.

High hepatitis C virus prevalence and incidence among Canadian intravenous drug users.

Roy E, Alary M, Morissette C, Leclerc P, Boudreau JF, Parent R, Rochefort J, Claessens C; SurvUDI Working Group.

Int J STD AIDS. 2007 Jan;18(1):23-7.

PMID:
17326858
16.

Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis.

Gervais F, Paquette J, Morissette C, Krzywkowski P, Yu M, Azzi M, Lacombe D, Kong X, Aman A, Laurin J, Szarek WA, Tremblay P.

Neurobiol Aging. 2007 Apr;28(4):537-47. Epub 2006 May 3.

PMID:
16675063
17.

The cAMP-specific phosphodiesterase 4B mediates Abeta-induced microglial activation.

Sebastiani G, Morissette C, Lagacé C, Boulé M, Ouellette MJ, McLaughlin RW, Lacombe D, Gervais F, Tremblay P.

Neurobiol Aging. 2006 May;27(5):691-701. Epub 2005 Jul 1.

PMID:
15993984
18.

Mouse syngenic in vitro blood-brain barrier model: a new tool to examine inflammatory events in cerebral endothelium.

Coisne C, Dehouck L, Faveeuw C, Delplace Y, Miller F, Landry C, Morissette C, Fenart L, Cecchelli R, Tremblay P, Dehouck B.

Lab Invest. 2005 Jun;85(6):734-46.

19.

Intraosseous infusion: not just for kids anymore.

DeBoer S, Seaver M, Morissette C.

Emerg Med Serv. 2005 Mar;34(3):54, 56-63; quiz 119. Review. No abstract available.

PMID:
15839538
20.

Differences in the amyloid-beta-induced inflammatory response in microglia from C57BL/6 and A/J strains of mice.

Dudal S, Morissette C, Lacombe D, Tremblay P, Gervais F.

J Neuroimmunol. 2004 Aug;153(1-2):26-35.

PMID:
15265660
21.

Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.

Dudal S, Krzywkowski P, Paquette J, Morissette C, Lacombe D, Tremblay P, Gervais F.

Neurobiol Aging. 2004 Aug;25(7):861-71.

PMID:
15212840
22.

Stereoselective interactions of peptide inhibitors with the beta-amyloid peptide.

Chalifour RJ, McLaughlin RW, Lavoie L, Morissette C, Tremblay N, Boulé M, Sarazin P, Stéa D, Lacombe D, Tremblay P, Gervais F.

J Biol Chem. 2003 Sep 12;278(37):34874-81. Epub 2003 Jul 2.

23.

ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels.

Chakfe Y, Seguin R, Antel JP, Morissette C, Malo D, Henderson D, Séguéla P.

J Neurosci. 2002 Apr 15;22(8):3061-9.

24.

Glycosaminoglycan mimetics: a therapeutic approach to cerebral amyloid angiopathy.

Gervais F, Chalifour R, Garceau D, Kong X, Laurin J, Mclaughlin R, Morissette C, Paquette J.

Amyloid. 2001 Jul;8 Suppl 1:28-35.

PMID:
11676287
25.

Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.

Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M, Kunicki S, Morissette C, Paquette J, Gervais F, Bergeron C, Fraser PE, Carlson GA, George-Hyslop PS, Westaway D.

J Biol Chem. 2001 Jun 15;276(24):21562-70. Epub 2001 Mar 15.

26.

Genetic and physical mapping of the mouse host resistance locus Lgn1.

Diez E, Beckers MC, Ernst E, DiDonato CJ, Simard LR, Morissette C, Gervais F, Yoshida SI, Gros P.

Mamm Genome. 1997 Sep;8(9):682-5. No abstract available.

PMID:
9271671
27.

High-resolution linkage map of mouse chromosome 13 in the vicinity of the host resistance locus Lgn1.

Beckers MC, Ernst E, Diez E, Morissette C, Gervais F, Hunter K, Housman D, Yoshida S, Skamene E, Gros P.

Genomics. 1997 Feb 1;39(3):254-63.

PMID:
9119362
28.

Lung phagocyte bactericidal function in strains of mice resistant and susceptible to Pseudomonas aeruginosa.

Morissette C, Francoeur C, Darmond-Zwaig C, Gervais F.

Infect Immun. 1996 Dec;64(12):4984-92.

29.

Terminal differentiation of murine resident peritoneal macrophages is characterized by expression of the STK protein tyrosine kinase, a receptor for macrophage-stimulating protein.

Iwama A, Wang MH, Yamaguchi N, Ohno N, Okano K, Sudo T, Takeya M, Gervais F, Morissette C, Leonard EJ, Suda T.

Blood. 1995 Nov 1;86(9):3394-403.

30.
31.
32.

Simple and Rapid Inhibition Enzyme Immunoassay for the Detection of Staphylococcal Enterotoxin B in Foods.

Morissette C, Goulet J, Lamoureux G.

J Food Prot. 1990 Oct;53(10):834-840. doi: 10.4315/0362-028X-53.10.834.

PMID:
31018282
33.

Production of Avid Rabbit Antibodies Against Staphylococcal Enterotoxins A and B.

Morissette C, Goulet J, Lamoureux G.

J Food Prot. 1990 Sep;53(9):782-785. doi: 10.4315/0362-028X-53.9.782.

PMID:
31018305

Supplemental Content

Loading ...
Support Center